Caspase inhibition: A potential therapeutic strategy in neurological diseases

Histology and Histopathology

Volumn 16, Issue 3, 2001, Pages 895-908

  Rideout, H J ^a   Stefanis, L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Caspase; Human; Mitochondria; Neurodegenerative; Neuronal death; Protein aggregation; Therapy; Toxic fragment

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE INHIBITOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN INJURY; CADAVER; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; DISEASE MODEL; DRUG CLASSIFICATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; FUNCTIONAL ASSESSMENT; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; MITOCHONDRION; MOLECULAR DYNAMICS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PARKINSON DISEASE; PROTEIN AGGREGATION; REVIEW; STIMULUS; SURVIVAL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; BRAIN INJURIES; BRAIN ISCHEMIA; CASPASES; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; NERVOUS SYSTEM DISEASES; NEURONS; PARKINSON DISEASE; PARKINSONIAN DISORDERS;

MAMMALIA;

EID: 0034888540     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
2. The Bcl-2 protein family: Arbiters of cell survival
3. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
4. A cell that dies during wild-type C. elegans development can function as a neuron in a ced-3 mutant
5. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
6. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development
7. Apoptosis and programmed cell death: A role in cerebral ischemia
8. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
9. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
10. Ischemia-induced neuronal apoptosis
11. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK
12. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury
13. Caspase-3 mediated neuronal death after traumatic brain injury in rats
14. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration
15. Apoptosis-inducing factor (AIF): A ubiquitos mitochondrial oxidoreductase in apoptosis
16. BAX is required for neuronal death after trophic factor deprivation and during development
17. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c
18. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases
19. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinium-induced toxicity of cultured fetal rat messencephalic dopamine neurons
20. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death
21. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons
22. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
23. Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity
24. Genetic control of programmed cell death in the nematode C. elegans
25. Apoptosis after traumatic human spinal cord injury
26. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation
27. Reduction of postraumatic brain injury and free radical production by inhibition of the caspase-1 cascade
28. Death commitment point is advanced by axotomy in sympathetic neurons
29. A licence to kill
30. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
31. Inhibition of ICE slows ALS in mice
32. Prevention of vertebrate neuronal death by the crmA gene
33. Inhibition of human caspases by peptide-based and macromolecular inhibitors
34. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation
35. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
36. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia
37. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
38. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
39. Apoptotic pathways: The roads to ruin
40. The central executioners of apoptosis: Caspases or mitochondria?
41. Cytosolic release of cytochrome c in a transgenic mouse model of familial amyotrophic lateral sclerosis
42. A yeast genetic assay for caspase cleavage of the amyloid-beta precursor protein
43. Differential requirement for caspase 9 in apoptotic pathways in vivo
44. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human dopamine neurons
45. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
46. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
47. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
48. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
49. A YAC mouse model for Huntington's disease with full-length mutant huntington, cytoplasmic toxicity, and selective striatal neurodegeneration
50. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8
51. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
52. Cell death mechanism in Parkinson's disease
53. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra
54. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation
55. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons
56. Involvement of caspase-3 in death of cortical neurons evoked by DNA damage
57. Mutant hintingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition
58. Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity
59. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
60. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
61. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
62. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
63. Mechanisms mediating caspase activation in cell death
64. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease
65. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury
66. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
67. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
68. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
69. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat
70. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons
71. Distinct mechanisms underline neurotoxin-mediated cell death in cultured dopaminergic neurons
72. Activation of caspase-3 in permanent and transient brain ischaemia in man
73. Neuronal death in brain infarcts in man
74. A cellular model that recapitulates major pathogenic steps of Huntington's disease
75. Programmed cell death in developing grafts of fetal substantia nigra
76. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
77. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
78. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event
79. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
80. Fas receptor and neuronal cell death after spinal cord ischemia
81. Genetics of programmed cell death in C. elegans: Past, present and future
82. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death
83. Histochemical detection of apoptosis in Parkinson's disease
84. Generation of neuronal intranuclear inclusions by polyglutamine-GFP: Analysis of inclusion clearance and toxicity as a function of polyglutamine length
85. Caspase inhibition increases embryonic striatal graft survival
86. Blocking cytochrome c activity within intact neurons inhibits apoptosis
87. Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells
88. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
89. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress
90. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
91. Alternative, non-secretase processing of Alzheimer's β-amyloid precursor protein during apoptosis by caspase-6 and -8
92. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
93. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
94. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies
95. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
96. Huntington acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
97. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
98. Non-specific effects of methyl ketone peptide inhibitors of caspases
99. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
100. Amyloid beta-induced neuronal death is bax-dependent but caspase-independent
101. DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis
102. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
103. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
104. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death
105. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons
106. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support
107. Caspase-2 (Nedd2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity
108. Mechanisms and genes of cellular suicide
109. DNA damage and activated caspase-3 expression in neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia
110. Mitochondrial release of caspase-2 and -9 during the apoptotic process
111. Substrate specificities of caspase family proteases
112. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
113. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease
114. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
115. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
116. Caspase-2 mediates neuronal cell death induced by beta-amyloid
117. The contrasting roles of ICE-family proteases and interleukin 1-β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation
118. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) down-regulation, in sympathetic neurons and PC12 cells
119. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
120. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein
121. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
122. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis
123. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis
124. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
125. Caspases and neurodegeneration: On the cutting edge of new therapeutic approaches
126. Reversible physiological alterations in sympathetic neurons deprived of NGF but protected from apoptosis by caspase inhibition or Bax deletion
127. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
128. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus
129. Autophagy is activated by apoptotic signalling in sympathetic neurons: An alternative mechanism of death execution
130. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease
131. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2
132. Autoproteolytic activation of pro-caspases by oligomerization
133. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
134. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death
135. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
136. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3